Lundbeck CEO joins board of directors at Syros Pharmaceuticals
![Photo: Gregers Tycho/Ritzau/Ritzau Scanpix](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13274698.ece/ALTERNATES/schema-16_9/20190219-080033-2-1920x1920we.jpg)
A fresh face has joined the board at the US-based biopharmaceutical company Syros Pharmaceuticals in the form of Deborah Dunsire, CEO at Lundbeck, a press release reveals.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.